
Sean E. Aeder
Examiner (ID: 9317, Phone: (571)272-8787 , Office: P/1642 )
| Most Active Art Unit | 1642 |
| Art Unit(s) | 1642 |
| Total Applications | 1910 |
| Issued Applications | 898 |
| Pending Applications | 205 |
| Abandoned Applications | 842 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 11993978
[patent_doc_number] => 20170298133
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-10-19
[patent_title] => 'A method of treating bone metastasis diseases, medicaments therefore, and a method of predicting the clinical outcome of treating bone metastasis diseases'
[patent_app_type] => utility
[patent_app_number] => 15/511959
[patent_app_country] => US
[patent_app_date] => 2015-08-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 24
[patent_no_of_words] => 12826
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15511959
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/511959 | Method of treating bone metastasis diseases, medicaments therefore, and a method of predicting the clinical outcome of treating bone metastasis diseases | Aug 17, 2015 | Issued |
Array
(
[id] => 10468996
[patent_doc_number] => 20150354013
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-12-10
[patent_title] => 'DETECTING NEOPLASM'
[patent_app_type] => utility
[patent_app_number] => 14/827013
[patent_app_country] => US
[patent_app_date] => 2015-08-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 15339
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14827013
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/827013 | Detecting neoplasm | Aug 13, 2015 | Issued |
Array
(
[id] => 11004185
[patent_doc_number] => 20160201135
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-07-14
[patent_title] => 'NOVEL ESTROGEN RECEPTOR MUTATIONS AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 14/820217
[patent_app_country] => US
[patent_app_date] => 2015-08-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 50402
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14820217
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/820217 | NOVEL ESTROGEN RECEPTOR MUTATIONS AND USES THEREOF | Aug 5, 2015 | Abandoned |
Array
(
[id] => 14145491
[patent_doc_number] => 10253104
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-04-09
[patent_title] => Bispecific antibodies against CD3[?] and BCMA
[patent_app_type] => utility
[patent_app_number] => 15/501620
[patent_app_country] => US
[patent_app_date] => 2015-08-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 49
[patent_figures_cnt] => 35
[patent_no_of_words] => 48989
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 82
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15501620
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/501620 | Bispecific antibodies against CD3[?] and BCMA | Aug 2, 2015 | Issued |
Array
(
[id] => 12002151
[patent_doc_number] => 20170306305
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-10-26
[patent_title] => 'NON-FUCOSYLATED PROTEIN AND METHODS THEREOF'
[patent_app_type] => utility
[patent_app_number] => 15/500509
[patent_app_country] => US
[patent_app_date] => 2015-07-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 23448
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15500509
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/500509 | Non-fucosylated protein and methods thereof | Jul 29, 2015 | Issued |
Array
(
[id] => 15851129
[patent_doc_number] => 10640830
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-05-05
[patent_title] => Drug selection for non-small cell lung cancer therapy
[patent_app_type] => utility
[patent_app_number] => 14/812979
[patent_app_country] => US
[patent_app_date] => 2015-07-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 35
[patent_no_of_words] => 20915
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 255
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14812979
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/812979 | Drug selection for non-small cell lung cancer therapy | Jul 28, 2015 | Issued |
Array
(
[id] => 17323837
[patent_doc_number] => 11214836
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-01-04
[patent_title] => Methods and devices for predicting anthracycline treatment efficacy
[patent_app_type] => utility
[patent_app_number] => 15/325472
[patent_app_country] => US
[patent_app_date] => 2015-07-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 9373
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 76
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15325472
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/325472 | Methods and devices for predicting anthracycline treatment efficacy | Jul 14, 2015 | Issued |
Array
(
[id] => 13746759
[patent_doc_number] => 10166304
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-01-01
[patent_title] => Antibody fragments for detecting cancer and methods of use
[patent_app_type] => utility
[patent_app_number] => 15/325696
[patent_app_country] => US
[patent_app_date] => 2015-07-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 37
[patent_no_of_words] => 21822
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15325696
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/325696 | Antibody fragments for detecting cancer and methods of use | Jul 9, 2015 | Issued |
Array
(
[id] => 10414295
[patent_doc_number] => 20150299306
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-10-22
[patent_title] => 'METHODS AND COMPOSITIONS FOR MODULATION OF OLFML3 MEDIATED ANGIOGENESIS'
[patent_app_type] => utility
[patent_app_number] => 14/793065
[patent_app_country] => US
[patent_app_date] => 2015-07-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 27
[patent_figures_cnt] => 27
[patent_no_of_words] => 24772
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14793065
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/793065 | METHODS AND COMPOSITIONS FOR MODULATION OF OLFML3 MEDIATED ANGIOGENESIS | Jul 6, 2015 | Abandoned |
Array
(
[id] => 10799534
[patent_doc_number] => 20160145691
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-05-26
[patent_title] => 'NOVEL ESTROGEN RECEPTOR MUTATIONS AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 14/753397
[patent_app_country] => US
[patent_app_date] => 2015-06-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 61190
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 17
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14753397
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/753397 | Estrogen receptor mutations and uses thereof | Jun 28, 2015 | Issued |
Array
(
[id] => 10405299
[patent_doc_number] => 20150290308
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-10-15
[patent_title] => 'MONOCLONAL ANTIBODIES FOR CSPG4 FOR THE DIAGNOSIS AND TREATMENT OF BASAL BREAST CARCINOMA'
[patent_app_type] => utility
[patent_app_number] => 14/748123
[patent_app_country] => US
[patent_app_date] => 2015-06-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 27562
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14748123
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/748123 | Monoclonal antibodies for CSPG4 for the diagnosis and treatment of basal breast carcinoma | Jun 22, 2015 | Issued |
Array
(
[id] => 13151881
[patent_doc_number] => 10092645
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-10-09
[patent_title] => Methods of treatment with antagonists against PD-1 and PD-L1 in combination with radiation therapy
[patent_app_type] => utility
[patent_app_number] => 14/740876
[patent_app_country] => US
[patent_app_date] => 2015-06-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 36
[patent_figures_cnt] => 34
[patent_no_of_words] => 10245
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 97
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14740876
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/740876 | Methods of treatment with antagonists against PD-1 and PD-L1 in combination with radiation therapy | Jun 15, 2015 | Issued |
Array
(
[id] => 13182235
[patent_doc_number] => 10106620
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-10-23
[patent_title] => Blocking CD38 using anti-CD38 F(ab')2 to protect NK cells
[patent_app_type] => utility
[patent_app_number] => 15/319344
[patent_app_country] => US
[patent_app_date] => 2015-06-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 47
[patent_no_of_words] => 12757
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15319344
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/319344 | Blocking CD38 using anti-CD38 F(ab')2 to protect NK cells | Jun 14, 2015 | Issued |
Array
(
[id] => 11025507
[patent_doc_number] => 20160222458
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-08-04
[patent_title] => 'Gene Expression Profile Breast Tumour Grading'
[patent_app_type] => utility
[patent_app_number] => 14/737807
[patent_app_country] => US
[patent_app_date] => 2015-06-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 86
[patent_figures_cnt] => 86
[patent_no_of_words] => 74697
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14737807
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/737807 | Gene Expression Profile Breast Tumour Grading | Jun 11, 2015 | Abandoned |
Array
(
[id] => 10461189
[patent_doc_number] => 20150346204
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-12-03
[patent_title] => 'MEK Mutations Conferring Resistance to MEK Inhibitors'
[patent_app_type] => utility
[patent_app_number] => 14/735973
[patent_app_country] => US
[patent_app_date] => 2015-06-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 38160
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14735973
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/735973 | MEK Mutations Conferring Resistance to MEK Inhibitors | Jun 9, 2015 | Abandoned |
Array
(
[id] => 10367434
[patent_doc_number] => 20150252439
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-09-10
[patent_title] => 'Methods and Compositions for Prostate Cancer Metastasis'
[patent_app_type] => utility
[patent_app_number] => 14/717248
[patent_app_country] => US
[patent_app_date] => 2015-05-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 16150
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14717248
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/717248 | Methods and compositions for prostate cancer metastasis | May 19, 2015 | Issued |
Array
(
[id] => 10374411
[patent_doc_number] => 20150259417
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-09-17
[patent_title] => 'Anti-Glypican 3 Antibody'
[patent_app_type] => utility
[patent_app_number] => 14/713416
[patent_app_country] => US
[patent_app_date] => 2015-05-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 30589
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14713416
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/713416 | Anti-Glypican 3 Antibody | May 14, 2015 | Abandoned |
Array
(
[id] => 14762107
[patent_doc_number] => 10392438
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-08-27
[patent_title] => Bispecific antibodies
[patent_app_type] => utility
[patent_app_number] => 15/309879
[patent_app_country] => US
[patent_app_date] => 2015-05-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 62
[patent_figures_cnt] => 107
[patent_no_of_words] => 67400
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15309879
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/309879 | Bispecific antibodies | May 12, 2015 | Issued |
Array
(
[id] => 10664014
[patent_doc_number] => 20160010158
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-01-14
[patent_title] => 'COMPOSITIONS AND METHODS OF TREATING CANCER HARBORING PIKC3A MUTATIONS'
[patent_app_type] => utility
[patent_app_number] => 14/711507
[patent_app_country] => US
[patent_app_date] => 2015-05-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 28965
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14711507
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/711507 | Compositions and methods of treating cancer harboring PIKC3A mutations | May 12, 2015 | Issued |
Array
(
[id] => 10657644
[patent_doc_number] => 20160003786
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-01-07
[patent_title] => 'Methods Of Detecting Cancer'
[patent_app_type] => utility
[patent_app_number] => 14/707089
[patent_app_country] => US
[patent_app_date] => 2015-05-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 12426
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 15
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14707089
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/707089 | Methods of detecting cancer | May 7, 2015 | Issued |